These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 36411674)
1. Predicting drug-target binding affinity through molecule representation block based on multi-head attention and skip connection. Zhang L; Wang CC; Chen X Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36411674 [TBL] [Abstract][Full Text] [Related]
2. GPCNDTA: Prediction of drug-target binding affinity through cross-attention networks augmented with graph features and pharmacophores. Zhang L; Wang CC; Zhang Y; Chen X Comput Biol Med; 2023 Nov; 166():107512. PubMed ID: 37788507 [TBL] [Abstract][Full Text] [Related]
3. Deep drug-target binding affinity prediction with multiple attention blocks. Zeng Y; Chen X; Luo Y; Li X; Peng D Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33866349 [TBL] [Abstract][Full Text] [Related]
4. AttentionDTA: Drug-Target Binding Affinity Prediction by Sequence-Based Deep Learning With Attention Mechanism. Zhao Q; Duan G; Yang M; Cheng Z; Li Y; Wang J IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(2):852-863. PubMed ID: 35471889 [TBL] [Abstract][Full Text] [Related]
5. MCL-DTI: using drug multimodal information and bi-directional cross-attention learning method for predicting drug-target interaction. Qian Y; Li X; Wu J; Zhang Q BMC Bioinformatics; 2023 Aug; 24(1):323. PubMed ID: 37633938 [TBL] [Abstract][Full Text] [Related]
6. A deep learning framework for predicting molecular property based on multi-type features fusion. Ma M; Lei X Comput Biol Med; 2024 Feb; 169():107911. PubMed ID: 38160501 [TBL] [Abstract][Full Text] [Related]
7. MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug-Target Binding Affinity Prediction. Wang S; Song X; Zhang Y; Zhang K; Liu Y; Ren C; Pang S Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176031 [TBL] [Abstract][Full Text] [Related]
8. Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2. Anwaar MU; Adnan F; Abro A; Khan RA; Rehman AU; Osama M; Rainville C; Kumar S; Sterner DE; Javed S; Jamal SB; Baig A; Shabbir MR; Ahsan W; Butt TR; Assir MZ Comput Biol Med; 2022 Feb; 141():105049. PubMed ID: 34823857 [TBL] [Abstract][Full Text] [Related]
9. CoaDTI: multi-modal co-attention based framework for drug-target interaction annotation. Huang L; Lin J; Liu R; Zheng Z; Meng L; Chen X; Li X; Wong KC Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36274236 [TBL] [Abstract][Full Text] [Related]
10. DeepCoVDR: deep transfer learning with graph transformer and cross-attention for predicting COVID-19 drug response. Huang Z; Zhang P; Deng L Bioinformatics; 2023 Jun; 39(39 Suppl 1):i475-i483. PubMed ID: 37387168 [TBL] [Abstract][Full Text] [Related]
11. Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model. Beck BR; Shin B; Choi Y; Park S; Kang K Comput Struct Biotechnol J; 2020; 18():784-790. PubMed ID: 32280433 [TBL] [Abstract][Full Text] [Related]
12. TEFDTA: a transformer encoder and fingerprint representation combined prediction method for bonded and non-bonded drug-target affinities. Li Z; Ren P; Yang H; Zheng J; Bai F Bioinformatics; 2024 Jan; 40(1):. PubMed ID: 38141210 [TBL] [Abstract][Full Text] [Related]
13. DE-MHAIPs: Identification of SARS-CoV-2 phosphorylation sites based on differential evolution multi-feature learning and multi-head attention mechanism. Wang M; Yan L; Jia J; Lai J; Zhou H; Yu B Comput Biol Med; 2023 Jun; 160():106935. PubMed ID: 37120990 [TBL] [Abstract][Full Text] [Related]
14. GeneralizedDTA: combining pre-training and multi-task learning to predict drug-target binding affinity for unknown drug discovery. Lin S; Shi C; Chen J BMC Bioinformatics; 2022 Sep; 23(1):367. PubMed ID: 36071406 [TBL] [Abstract][Full Text] [Related]
15. [Homologous modeling and binding ability analysis of Spike protein after point mutation of severe acute respiratory syndrome coronavirus 2 to receptor proteins and potential antiviral drugs]. Cao Z; Wang LT; Liu ZM Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 53(1):150-158. PubMed ID: 33550350 [TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
17. Adaptive learning embedding features to improve the predictive performance of SARS-CoV-2 phosphorylation sites. Jiao S; Ye X; Ao C; Sakurai T; Zou Q; Xu L Bioinformatics; 2023 Nov; 39(11):. PubMed ID: 37847658 [TBL] [Abstract][Full Text] [Related]
18. Efficient machine learning model for predicting drug-target interactions with case study for Covid-19. El-Behery H; Attia AF; El-Feshawy N; Torkey H Comput Biol Chem; 2021 Aug; 93():107536. PubMed ID: 34271420 [TBL] [Abstract][Full Text] [Related]
19. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. Kumar Y; Singh H; Patel CN J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274 [TBL] [Abstract][Full Text] [Related]